Looking at 'cost' and 'value' under different evaluation processes
Daniel Liden, Context Matters
Advertisement
Articles by Daniel Liden, Context Matters
Advertisement
Latest Updated Articles
- A case study in differing approaches to reimbursement approval in Europe and the US
Published: March 9th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Cambrex Commits $120 Million to Grow US API Manufacturing
2
Direct-to-patient: pharma’s next power move
3
Pharma Pulse: Alkermes Acquires Avadel in $2.1B Deal, BioNTech Moves to Buy CureVac, and MedTech Industry Embraces Digital-First Models
4
